Agency News: Concentric Pharma Advertising, Intouch Solutions

Share this article:

Full-service agency Concentric Pharma Advertising has announced that business transfer organization MDC Partners has acquired a majority stake in the firm. This acquisition marks MDC Partners's first significant stake in healthcare marketing in the US, already having been established as a company with a valued network of shops in the consumer world, including innovative ad firm Crispin Porter + Bogusky. With offices in New York and London, Concentric's current roster of pharma clients includes Pfizer, Novartis, Amgen, Allergan and Genentech, in addition to being named as the AOR for the rheumatology indication of Enbrel, a product of Pfizer and Amgen. Financials for this transaction were undisclosed.

Kansas City-headquartered digital agency Intouch Solutions has brought its nationwide office count to three, after opening a third branch of the company today in Midtown Manhattan. The company opened up a second office, in Chicago, in 2008. Intouch has also announced its first hire at its New York City location: Jack Lipton, SVP, client services, who joined the agency this month after gaining extensive pharma marketing experience with agencies such as GQ and MRM, to name a few. At present, senior management from Intouch's Kansas head office will oversee the business's operations in New York.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.